Nutritional intake
Personal habits i.e. smoking, recreational drug use,
exercise
Any accidents or experienced intimate partner abuse
ESTIMATING FETAL GROWTH
McDonald’s Rule – a symphysis-fundal height measurement
A common method of determining during mid-pregnancy,
that a fetus is growing in the utero
Typically, the distance from the uterine fundus to the
symphysis pubis in centimetres is equal to the week of
gestation between the 20th and 31st weeks of pregnancy
McDonald’s rule becomes inaccurate during the third
trimester because fetus is growing more in weight than in
height.
Fundal height much greater than the standard suggests
multiple pregnancy, a large-for-gestational-age infant,
hydramnios or possibly even a hydatidiform mole
ESTIMATING FETAL GROWTH
Fundal height, or
McDonald's Rule, is a
measure of the size of the
uterus to assess fetal growth
and development.
ESTIMATING FETAL GROWTH
Determining and recording that the
fundus has reached typical milestone
measurement, such as:
Over the symphysis pubis = 12 weeks
At the umbilicus = 20 weeks
at the xiphoid process = 38 weeks
ASSESSING FETAL WELL-BEING
ASSESSING FETAL WELL-BEING
CHORIONIC VILLI SAMPLING
ASSESSING FETAL WELL-BEING
AMNIOCENTESIS
From the Greek word amnion for sac and kentesis for puncture
Aspiration of amniotic fluid from the pregnant uterus for
examination
Procedure can be done at the physician’s office or in an
ambulatory clinic
Typically scheduled between the 14th and 16th weeks of
pregnancy to allow for a generous amount of amniotic fluid to
be present.
The technique can be used again near term to test for fetal
maturity.
ASSESSING FETAL WELL-BEING
AMNIOCENTESIS
ASSESSING FETAL WELL-BEING
AMNIOCENTESIS
PROCEDURE:
Ask the woman to void – to reduce bladder size, thus
preventing inadvertent puncture
Place her in a supine position on the examining table and
drape her appropriately, exposing only her abdomen.
Place a folded towel under her right buttock to tip her
body slightly to the left and move the uterus off the vena
cava, preventing supine hypotension syndrome
ASSESSING FETAL WELL-BEING
AMNIOCENTESIS
PROCEDURE:
Take the maternal blood pressure and measure FHR for
baseline levels
Explain that a sonogram will be done to determine the position
of the fetus, a pocket of amniotic fluid, and the placenta.
The abdomen will be washed with an antiseptic solution, and a
local anesthesia will be given.
Caution the woman that she may feel a sensation of pressure as
the needle used for aspiration, a 3 in. or 4 in., 20 to 22 gauge
spinal needle is introduced
Do not suggest that she take a deep breath and hold it as a
distraction against discomfort; this lowers the diaphragm
against the uterus and shifts intrauterine contents.
ASSESSING FETAL WELL-BEING
AMNIOCENTESIS
PROCEDURE:
The needle is inserted into the amniotic cavity over a pool of
amniotic fluid, carefully avoiding the fetus and placenta
A syringe is attached and about 15ml of amniotic fluid is
withdrawn.
The needle is then removed, and the woman rests quietly for
about 30 minutes
During the procedure and for the 30 minutes afterward,
observe the FHR monitor to be certain the rate remains normal,
and observe the uterine contraction monitor to be sure that no
contractions are occurring.
ASSESSING FETAL WELL-BEING
AMNIOCENTESIS
PROCEDURE:
If the woman has Rh-negative blood, Rho(D) immune globulin
(RhIG; RhoGAM) may be administered after the procedure to
prevent fetal isommunization. This is to ensure that maternal
antibodies will not form against any placental red blood cells
that might have accidentally been released during the procedure
Amniocentensis can provide information in a number of areas:
Color
Lecithin/Sphingomyelin ratio
Phospatidyl Glycerol and Desaturated Phosphatidylcholine
Bilirubin determination
Chromosome analysis
Fetal fibronectin
Inborn errors of metabolism
Alpha-fetoprotein
ASSESSING FETAL WELL-BEING
AMNIOCENTESIS
ASSESSING FETAL WELL-BEING
AMNIOCENTESIS
LECITHIN/SPHINGOMYELIN RATIO
Lecithin and sphingomyelin are the protein components of
the lung enzyme surfactant that the alveoli begin to form
at 22nd to 24th weeks of pregnancy.
After amniocentesis, the L/S ratio may be determined
quickly by a shake test – (if bubbles appear in the amniotic
fluid after shaking, the ratio is mature) or it can be sent for
laboratory analysis.
An L/S ratio of 2:1 is traditionally accepted as lung
maturity.
ASSESSING FETAL WELL-BEING
AMNIOCENTESIS
LECITHIN/SPHINGOMYELIN RATIO
Infants of mothers with severe diabetes may have false
mature readings of lecithin because the stress to the
infant in utero tends to mature lecithin pathways easily.
Infant may be born with mature lung function but be
immature overall (fragile giants) and thus may not do
well in postnatal life.
Some laboratories interpret a ratio of 2.5:1 or 3:1 as a
mature indicator in infants of diabetic mothers
ASSESSING FETAL WELL-BEING
AMNIOCENTESIS
BILIRUBIN DETERMINATION
Presence of bilirubin may be analyzed if a blood
incompatibility is suspected.
If bilirubin is going to be analyzed, the specimen must
be free of blood or a false-positive reading will occur.
ASSESSING FETAL WELL-BEING
AMNIOCENTESIS
CHROMOSOME ANALYSIS
A few fetal skin cells are always present in amniotic
fluid. These cells may be cultured for karyotyping.
ASSESSING FETAL WELL-BEING
AMNIOCENTESIS
FETAL FIBRONECTIN
Fibronectin is a glycoprotein that plays a part in helping
the placenta attach to the uterine deciduas. It can be
found in abundant amounts to the uterine deciduas.
Early in pregnancy, it can be assessed in the woman’s
cervical mucus, but the amount then fades, after 20 weeks
of pregnancy, it is no longer present.
As labor approaches and cervical dilatation begins, it can
be assessed again in cervical or vaginal fluid.
ASSESSING FETAL WELL-BEING
AMNIOCENTESIS
FETAL FIBRONECTIN
Damage to fetal membranes releases a great deal of
the substance, so detection of fibronectin in the
amniotic fluid or in the mother’s vagina can serve as
announcement that preterm labor may be beginning.
ASSESSING FETAL WELL-BEING
AMNIOCENTESIS
ALPHA-FETOPROTEIN
• If a fetus is found anemic, blood may be transfused using the same technique
Because the umbilical vein continues to ooze for a moment after the procedure,
fetal blood could enter the maternal circulation, so RhIG is given to Rh-negative
women to prevent sensitization.
Fetus is monitored by a nonstress test before and after the procedure to be certain
that uterine contractions are not present and by ultrasound to see that no
bleeding is evident.
PUBS carries little additional risk to the fetus or mother over amniocentesis and
can yield information not available by any other means, especially about blood
dyscrasias (an imbalance components of blood).
ASSESSING FETAL WELL-BEING
AMNIOSCOPY
ASSESSING FETAL WELL-BEING
FETOSCOPY
ASSESSING FETAL WELL-BEING
FETOSCOPY
PROCEDURE
Mother is prepared and draped as for amniocentesis
Local anesthesia is injected into the abdominal skin
Fetoscope is then inserted through a minor abdominal incision
If the fetus is very active, meperidine (Demerol) may be administered to the mother –
this drug crosses the placenta and sedates the fetus, to avoid fetal injury by the scope to
allow better observation
Fetoscopy carries a small risk of premature labor
Amnionitis (infection of the amniotic fluid) may occur – to avoid this, mother may be
prescribed 10 days of antibiotic therapy after the procedure
ASSESSING FETAL WELL-BEING
BIOPHYSICAL PROFILE
Combines five parameters into one assessment :
Fetal activity
Fetal breathing movements
Fetal body movement
Fetal tone
Amniotic fluid volume
Fetal heart and breathing record measures short-term nervous system function
Amniotic fluid volume helps measure long-term adequacy of placental function
ASSESSING FETAL WELL-BEING
BIOPHYSICAL PROFILE
By this system, each item has the potential for scoring a 2, so 10
would be the highest score possible.
Biophysical profile is more accurate in predicting fetal well-being
than any single assessment. Because the scoring is similar to that
of the Apgar score determined at birth on infants, it is popularly
called FETAL APGAR
It may be done as often as daily during a high-risk pregnancy.
ASSESSING FETAL WELL-BEING
BIOPHYSICAL PROFILE
If the fetus score on a complete profile is 8 to 10, the fetus is considered to be doing
well
A score of 6 is considered suspicious
A score of 4 denotes fetal jeopardy
At present, some centers use only two assessments (amniotic fluid index and
nonstress test), it is referred to as MODIFIED BIOPHYSICAL PROFILE, it predicts
short-term viability by nonstress test and long-term viability by the amniotic fluid
index.
Nurses play a large role in obtaining the information for both the modified and the
full biophysical profile by obtaining either the nonstress or the sonogram reading.
BIOPHYSICAL PROFILE SCORING
ASSESSMENT INSTRUMENT CRITERIA FOR A
SCORE OF 2
FETAL BREATHING Sonogram At least one episode of 30
sec of sustained fetal
breathing movements
within 30 min of
observation
FETAL MOVEMENT Sonogram At least three separate
episodes of fetal limb or
trunk movement w/in a
30-min observation
FETAL TONE Sonogram The fetus must extend
and then flex the
extremities or spine at
least once in 30 min
BIOPHYSICAL PROFILE SCORING
ASSESSMENT INSTRUMENT CRITERIA FOR A
SCORE OF 2
AMNIOTIC FLUID Sonogram A pocket of amniotic
VOLUME fluid measuring more
than 1 cm in vertical
diameter must be present
FETAL HEART Nonstress Test Two or more FHR
REACTIVITY accelerations of at least
15bpm above baseline
and of 15 sec duration
with fetal movements
over a 20-min time
period